1. Hou, Tianyun, Tian, Yuan, Cao, Ziyang, Yang, Yang, Zhu, Wei-Guo. 2022. Cytoplasmic SIRT6-mediated ACSL5 deacetylation impedes nonalcoholic fatty liver disease by facilitating hepatic fatty acid oxidation. In Molecular cell, 82, 4099-4115.e9. doi:10.1016/j.molcel.2022.09.018. https://pubmed.ncbi.nlm.nih.gov/36208627/
2. Quan, Jing, Bode, Ann M, Luo, Xiangjian. 2021. ACSL family: The regulatory mechanisms and therapeutic implications in cancer. In European journal of pharmacology, 909, 174397. doi:10.1016/j.ejphar.2021.174397. https://pubmed.ncbi.nlm.nih.gov/34332918/
3. Yuan, Hua, Li, Xuemei, Zhang, Xiuying, Kang, Rui, Tang, Daolin. 2016. Identification of ACSL4 as a biomarker and contributor of ferroptosis. In Biochemical and biophysical research communications, 478, 1338-43. doi:10.1016/j.bbrc.2016.08.124. https://pubmed.ncbi.nlm.nih.gov/27565726/
4. O'Brien, Mitchell J, Beijerink, Niek J, Sansom, Mandy, Chew, Tracy, Wade, Claire M. 2020. A large deletion on CFA28 omitting ACSL5 gene is associated with intestinal lipid malabsorption in the Australian Kelpie dog breed. In Scientific reports, 10, 18223. doi:10.1038/s41598-020-75243-x. https://pubmed.ncbi.nlm.nih.gov/33106515/
5. Xi, Yiyun, Yang, Ming, Deng, Zebin, Tang, Chengyuan, Sun, Lin. 2024. ACSL5 promotes lipid deposition and lipoapoptosis in proximal tubular epithelial cells of diabetic kidney disease. In Molecular and cellular endocrinology, 595, 112418. doi:10.1016/j.mce.2024.112418. https://pubmed.ncbi.nlm.nih.gov/39557186/
智鼠故事 
